Conducted in July 2026, the flash survey gathered responses from 31 companies primarily in the technology, industrial and manufacturing, energy, and healthcare sectors . This article breaks down the survey's key findings on export losses, market-share erosion, and the futility of controlling items that competitors readily supply.

The Core Finding: Self-Inflicted Market Exile

The survey's headline finding is that the licensing regime is backfiring. By imposing months-long delays on export licenses, Washington is effectively shutting American companies out of the Chinese market without preventing Chinese customers from getting the products . One analysis described this as "self-imposed market exile" .

• Billions in lost exports: Months-long licensing delays are costing the United States billions of dollars in exports .
• Eroded market share: US firms are losing market share globally and in China as foreign competitors fulfill orders more quickly .
• No strategic gain: Most pending export licenses are for items already available in China from Chinese or international suppliers, meaning the controls achieve little strategic benefit .

How the Licensing Regime Fails American Companies

The survey details the specific mechanisms by which the regime harms US businesses.

Months-Long Delays and Unclear Procedures

Respondents described a slow, opaque system with a lack of agency engagement. The survey flagged license delays as the most common challenge, identified by 95% of companies . For items bound for Chinese customers, two-thirds of companies reported facing delays of four months or longer . The regime is characterized by unclear procedures and an unwillingness of export control agencies to engage with industry .

Eroding Competitiveness and R&D Capacity

Poorly calibrated controls don't just lose sales; they weaken American competitiveness over the long term. By ceding market share to foreign rivals, the controls reduce the profits available for research and development (R&D), undermining the US's long-term innovation capacity . The USCBC's larger 2026 Member Survey, based on 175 responses, also found that export controls are less effective when Chinese or foreign competitors can readily backfill the supply .

The Fatal Flaw: Controlled Items Are Already Available in China

The most damning finding is the survey's conclusion on market realities. The survey found that most pending export licenses cover products that are "already available in China from Chinese or international suppliers" . This means the controls do not deny China access to the technology; they merely deny the business to American companies.

"US export controls are not calibrated to empower American companies. While intended to restrict access to critical technologies and inputs, export controls are less effective when Chinese or foreign competitors can readily backfill." — USCBC Member Survey 2026

Broader Context from Other USCBC Surveys

The flash survey's findings align with USCBC's broader 2026 Member Survey, which found that:

• 95% of companies consider their China operations important for staying competitive globally .
• 72% of companies reported being affected by tariffs .
• Around 40% of companies reported negative effects from US export control policies, including lost sales and severed customer relationships .

Implications for US Policy

The USCBC flash survey suggests that the current export-control approach is counterproductive. The delays and unclear procedures are not only costing American companies billions but are also failing to advance the stated policy goal of restricting China's access to critical technologies . The survey indicates that the regime needs recalibration to be effective, moving from a system that punishes US firms to one that genuinely limits competitors' access while keeping American companies competitive.

Conclusion

The USCBC's July 2026 flash survey provides concrete data showing that the Trump administration's export-control licensing regime is a costly failure for US industry. The regime is slow, opaque, and ineffective, costing billions in lost exports while failing to prevent China from acquiring the same technologies from other global suppliers. The central takeaway from the survey is clear: the current policy punishes American companies without achieving its strategic purpose.

Conducted in July 2026, the flash survey gathered responses from 31 companies primarily in the technology, industrial and manufacturing, energy, and healthcare sectors . This article breaks down the survey's key findings on export losses, market-share erosion, and the futility of controlling items that competitors readily supply.

The Core Finding: Self-Inflicted Market Exile

The survey's headline finding is that the licensing regime is backfiring. By imposing months-long delays on export licenses, Washington is effectively shutting American companies out of the Chinese market without preventing Chinese customers from getting the products . One analysis described this as "self-imposed market exile" .

• Billions in lost exports: Months-long licensing delays are costing the United States billions of dollars in exports .
• Eroded market share: US firms are losing market share globally and in China as foreign competitors fulfill orders more quickly .
• No strategic gain: Most pending export licenses are for items already available in China from Chinese or international suppliers, meaning the controls achieve little strategic benefit .

How the Licensing Regime Fails American Companies

The survey details the specific mechanisms by which the regime harms US businesses.

Months-Long Delays and Unclear Procedures

Respondents described a slow, opaque system with a lack of agency engagement. The survey flagged license delays as the most common challenge, identified by 95% of companies . For items bound for Chinese customers, two-thirds of companies reported facing delays of four months or longer . The regime is characterized by unclear procedures and an unwillingness of export control agencies to engage with industry .

Eroding Competitiveness and R&D Capacity

Poorly calibrated controls don't just lose sales; they weaken American competitiveness over the long term. By ceding market share to foreign rivals, the controls reduce the profits available for research and development (R&D), undermining the US's long-term innovation capacity . The USCBC's larger 2026 Member Survey, based on 175 responses, also found that export controls are less effective when Chinese or foreign competitors can readily backfill the supply .

The Fatal Flaw: Controlled Items Are Already Available in China

The most damning finding is the survey's conclusion on market realities. The survey found that most pending export licenses cover products that are "already available in China from Chinese or international suppliers" . This means the controls do not deny China access to the technology; they merely deny the business to American companies.

"US export controls are not calibrated to empower American companies. While intended to restrict access to critical technologies and inputs, export controls are less effective when Chinese or foreign competitors can readily backfill." — USCBC Member Survey 2026

Broader Context from Other USCBC Surveys

The flash survey's findings align with USCBC's broader 2026 Member Survey, which found that:

• 95% of companies consider their China operations important for staying competitive globally .
• 72% of companies reported being affected by tariffs .
• Around 40% of companies reported negative effects from US export control policies, including lost sales and severed customer relationships .

Implications for US Policy

The USCBC flash survey suggests that the current export-control approach is counterproductive. The delays and unclear procedures are not only costing American companies billions but are also failing to advance the stated policy goal of restricting China's access to critical technologies . The survey indicates that the regime needs recalibration to be effective, moving from a system that punishes US firms to one that genuinely limits competitors' access while keeping American companies competitive.

Conclusion

The USCBC's July 2026 flash survey provides concrete data showing that the Trump administration's export-control licensing regime is a costly failure for US industry. The regime is slow, opaque, and ineffective, costing billions in lost exports while failing to prevent China from acquiring the same technologies from other global suppliers. The central takeaway from the survey is clear: the current policy punishes American companies without achieving its strategic purpose.